DIALYSIS · CCN 292515

DaVita Summerlin Dialysis Center

LAS VEGAS, NV 89144

DialysisProfitDaVita
$5.2M
TOTAL REVENUE
31.5%
OPERATING MARGIN
3 / 5
STAR RATING
12
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$5.2M
Total costs
$3.6M
Operating income (rev − costs)
$1.6M
Operating margin
31.5%
Total charges
$5.1M
Total treatments
12,342
Dialysis stations
20

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

12 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.5975—
Fistula Rate
DFC_FISTULA_RATE
57.9102—
Five Star Rating
DFC_FIVE_STAR
3——
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
162.193—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.36——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
11102—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
16404—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
6.961—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
29.470—
Standardized ED Visits Ratio
DFC_SEDR
0.6951—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
18.942—